Reply: Reduction in Risk of Disease Progression With Triple Therapy: Is it True for All?

Free article

Comment

Kelly M Chin et al. J Am Coll Cardiol. 2022.

Free article

. 2022 Feb 22;79(7):e177.

doi: 10.1016/j.jacc.2021.12.006.

No abstract available

Comment on

Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension.
Chin KM, Sitbon O, Doelberg M, Feldman J, Gibbs JSR, Grünig E, Hoeper MM, Martin N, Mathai SC, McLaughlin VV, Perchenet L, Poch D, Saggar R, Simonneau G, Galiè N. Chin KM, et al. J Am Coll Cardiol. 2021 Oct 5;78(14):1393-1403. doi: 10.1016/j.jacc.2021.07.057. J Am Coll Cardiol. 2021. PMID: 34593120 Clinical Trial.
Reduction in Risk of Disease Progression With Triple Therapy: Is It True for All?
Ross RD. Ross RD. J Am Coll Cardiol. 2022 Feb 22;79(7):e175. doi: 10.1016/j.jacc.2021.11.049. J Am Coll Cardiol. 2022. PMID: 35177201 No abstract available.